RNA Research Solutions
-
R1128 EZ Cap™ SaCas9 mRNA (m1Ψ)Summary: SaCas9 mRNA with Cap 1 structure, modified by m1Ψ, providing higher transcription efficiency, and suppressing RNA-mediated innate immune activation -
R1125 EZ Cap™ Nano Luciferase mRNASummary: NLuc mRNA with Cap 1 structure, providing higher transcription efficiency -
R1126 EZ Cap™ Nano Luciferase mRNA (m1Ψ)Summary: NLuc mRNA with Cap 1 structure, modified by m1Ψ, providing higher transcription efficiency, and suppressing RNA-mediated innate immune activation -
C8811 DSPE-DBCOSummary: A clickable functionalized phospholipid scaffold -
R1129 EZ Cap™ Gaussia Luciferase mRNA (m1Ψ)Summary: GLuc mRNA with Cap 1 structure, modified by m1Ψ, providing higher transcription efficiency, and suppressing RNA-mediated innate immune activation -
M2020 DSPE-PEG2000-NHSSummary: PEG lipids with NHS groups, used for targeted delivery of liposomes -
R1131 EZ Cap™ BCMA CAR mRNASummary: BCMA CAR mRNA with Cap 1 structure, providing higher transcription efficiency -
R1132 EZ Cap™ BCMA CAR mRNA (5-moUTP)Summary: BCMA CAR mRNA with Cap 1 structure, modified by 5-moUTP, providing higher transcription efficiency, and suppressing RNA-mediated innate immune activation -
R1133 Enhanced EZ Cap™ EGFP mRNASummary: Sequence-optimized EGFP mRNA with Cap 1 structure, significantly enhances the protein expression efficiency -
R1134 Enhanced EZ Cap™ EGFP mRNA (m1Ψ)Summary: Sequence-optimized EGFP mRNA with Cap 1 structure, modified by m1Ψ, significantly enhances the protein expression efficiency
